Showing results (21-30 of 90) with videos related to
Sort By:
Pageof 9
Journal of the International AIDS Society|March 23, 2023
Adolescent and young adult research across the HIV prevention and care continua: an international programme analysis and targeted reviewSamantha Calabrese, Matt Perkins, Sonia Lee, et al.Journal of the International AIDS Society|March 1, 2019
Acquisition of Sexually Transmitted Infections among Women Using a Variety of Contraceptive Options: A prospective Study among High-risk African WomenFlavia Matovu Kiweewa, Elizabeth Brown, Anu Mishra, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|January 11, 2020
Darunavir Pharmacokinetics With an Increased Dose During PregnancyAhizechukwu C Eke, Alice M Stek, Jiajia Wang, et al.American Journal of Obstetrics and Gynecology|July 20, 2020
Maternal mortality in the United States: research gaps, opportunities, and prioritiesJuanita J Chinn, Esther Eisenberg, Shavon Artis Dickerson, et al.Human Vaccines & Immunotherapeutics|December 9, 2014
Comparative humoral and cellular immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: follow-up through Month 48 in a Phase III randomized studyMark H Einstein, Myron J Levin, Archana Chatterjee, et al.Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|November 4, 2020
Using a Composite Maternal-Infant Outcome Measure in Tuberculosis-Prevention Studies Among Pregnant WomenGrace Montepiedra, Soyeon Kim, Adriana Weinberg, et al.Journal of Acquired Immune Deficiency Syndromes (1999)|March 13, 2018
Rilpivirine Plasma and Cervicovaginal Concentrations in Women During Pregnancy and PostpartumAhizechukwu C Eke, Nahida Chakhtoura, Angela Kashuba, et al.Human Vaccines & Immunotherapeutics|December 9, 2014
Comparison of long-term immunogenicity and safety of human papillomavirus (HPV)-16/18 AS04-adjuvanted vaccine and HPV-6/11/16/18 vaccine in healthy women aged 18-45 years: end-of-study analysis of a Phase III randomized trialMark H Einstein, Peter Takacs, Archana Chatterjee, et al.AIDS (London, England)|January 26, 2018
Dolutegravir pharmacokinetics in pregnant and postpartum women living with HIVNikki Mulligan, Brookie M Best, Jiajia Wang, et al.Plos One|June 30, 2023
Development and validation of a prediction tool to support engagement in HIV care among young people ages 10-24 years in KenyaKate Wilson, Kawango Agot, Jessica Dyer, et al.Pageof 9